Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, November 2002, p. 1396-1397, Vol. 9, No. 6
1071-412X/02/$04.00+0 DOI: 10.1128/CDLI.9.6.1396-1397.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Laboratory for Experimental Internal Medicine, Academic Medical Centre, 1105 AZ Amsterdam, The Netherlands
Received 13 March 2002/ Returned for modification 30 May 2002/ Accepted 2 August 2002
Warfarin, a widely prescribed drug for preventing thrombosis, is thought to act solely through inhibition of vitamin K-dependent coagulation factors. Low concentrations of warfarin inhibit interleukin-6 production and phosphorylation of I-
B but not activation of p38 mitogen-activated protein kinase. Thus, warfarin inhibits inflammatory signal transduction, and this may contribute to clinical effects of warfarin.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |